Clinical Trial Update: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluated PG2 for improving fatigue in advanced cancer patients receiving standard palliative care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PG2

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Fatigue | Phase 2, Phase 3 | Status: COMPLETED